Great Eastern
Great Eastern posts 79% jump in Q4 profit to S$241.4 million, boosts HNW focus
The board proposes final dividend of S$0.30 per share for the financial year ended December
Singapore insurers brace for 2026 as medical inflation climbs and IP rules tighten
Despite challenges, longer-term demographic and wealth trends remain supportive, observers say
SGX’s initiatives, Great Eastern’s annual run raise almost S$3 million
Beneficiaries include children with special needs, seniors and lower-income households
Stocks to watch: Keppel, Great Eastern, MIT, Hong Leong Asia, CLCT, Starhill Global Reit
[SINGAPORE] The following companies saw new developments that may affect trading of their securities on Thursday (Oct 30):
Great Eastern Q3 net profit up 36% at S$372 million amid higher new business embedded value
Growth is driven by robust results from shareholders’ fund segment, which is up 45% on the year for the nine months ended Sep 30
Great Eastern up 2.7%, hits highest price since trading resumption during market hours
Insurer’s shares were suspended in July 2024 after its free float fell under 10% following a failed takeover bid by its parent OCBC
Great Eastern sets sights on expanding high-net-worth capabilities, doubling new business value
The listed insurer is looking to capitalise on Asia’s unprecedented wealth creation
Great Eastern resumes trading after year-long suspension; closes 10% lower than OCBC’s best offer
The counter last traded at S$25.80 in July 2024
Great Eastern to resume trading on Aug 21 as bonus issue lifts free float to above 10%
Public shareholders will have 11.76% of voting rights in the insurer
Great Eastern Q2 earnings down 11% at S$248.2 million due to lower contribution from insurance business
Bonus ordinary shares and Class C shares set to be issued as insurer aims to resume trading
